XML 55 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Information
 6 Months Ended
Jul. 01, 2017
Segment Reporting [Abstract]  
Segment information
SEGMENT INFORMATION
    
Our reporting segments are as follows:

•
CHCA, comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract, infant formula and Animal Health categories).
•
CHCI, comprises our legacy Branded Consumer Healthcare segment and now includes our consumer focused businesses in the U.K., Australia, and Israel. This segment also includes our U.K. liquid licensed products business.
•
RX, comprises our U.S. Prescription Pharmaceuticals business.

We also have an "Other" reporting segment that consists of our legacy API business, which does not meet the quantitative threshold required to be a separately reportable segment. Effective January 1, 2017, due to the sale of the Tysabri® financial asset, all legal expenses associated with the former Specialty Sciences segment were moved to unallocated expenses. Our segments reflect the way in which our chief operating decision maker reviews our operating results and allocates resources.

The below tables show select financial measures by reporting segment (in millions):
 
 
Total Assets
 
 
July 1,
2017
 
December 31,
2016
CHCA
 
$
3,907.1

 
$
3,351.3

CHCI
 
5,012.1

 
4,795.2

RX
 
2,560.8

 
2,646.4

Specialty Sciences
 
—

 
2,775.8

Other
 
312.2

 
301.4

Total
 
$
11,792.2

 
$
13,870.1

 
Three Months Ended
 
July 1, 2017
 
July 2, 2016
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
604.9

 
$
104.2

 
$
17.0

 
$
629.9

 
$
116.8

 
$
17.6

CHCI
376.5

 
3.9

 
47.5

 
415.9

 
0.6

 
44.9

RX
240.4

 
69.3

 
22.3

 
276.9

 
92.6

 
25.9

Specialty Sciences
—

 
—

 
—

 
—

 
(3.8
)
 
—

Other
16.1

 
4.1

 
0.4

 
17.8

 
(1.3
)
 
0.5

Unallocated
—

 
(32.7
)
 
—

 
—

 
(20.1
)
 
—

Total
$
1,237.9

 
$
148.8

 
$
87.2

 
$
1,340.5

 
$
184.8

 
$
88.9



 
Six Months Ended
 
July 1, 2017
 
July 2, 2016
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net
Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHCA
$
1,187.6

 
$
179.2

 
$
34.2

 
$
1,269.0

 
$
217.4

 
$
35.7

CHCI
751.5

 
4.2

 
93.2

 
855.3

 
(395.8
)
 
86.1

RX
457.8

 
157.5

 
44.6

 
525.0

 
184.0

 
51.4

Specialty Sciences
—

 
—

 
—

 
—

 
(5.2
)
 
—

Other
35.0

 
9.7

 
0.8

 
38.5

 
4.2

 
0.9

Unallocated
—

 
(73.3
)
 
—

 
—

 
(51.4
)
 
—

Total
$
2,431.9

 
$
277.3

 
$
172.8

 
$
2,687.8

 
$
(46.8
)
 
$
174.1